[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595831":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":33,"responsibleParty":60,"collaborators":63,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":18,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":18,"enrollmentInfo":78,"targetDuration":18,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":90,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"The University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Pharmacy chatbot intervention group","EXPERIMENTAL","In this arm, participants will receive a pharmacy chatbot intervention. They will be invited to use the chatbot through WhatsApp. They can ask questions regarding their (or the patient they are caring for) prescribed medications and get immediate responses from the chatbot. The intervention will last for 7 days.",[13],"Other: An AI pharmacy chatbot offering information related to HA-prescribed medication for hyperglycaemia, hypertension, and hyperlipidaemia",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","The control group will not have any exposure with the chatbot during the intervention period.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"An AI pharmacy chatbot offering information related to HA-prescribed medication for hyperglycaemia, hypertension, and hyperlipidaemia","It is a chatbot for HA-prescribed medication used for treating hyperglycaemia, hypertension, and hyperlipidaemia, available through WhatsApp. All the responses will be extracted from a database, in which the content was obtained from and validated by pharmacists from the Chief Pharmacist's Office of the Hospital Authority in Hong Kong. The intervention period will last for 7 days.",[9],[25],{"name":26,"affiliation":5,"role":27},"Joseph Wu, PhD","PRINCIPAL_INVESTIGATOR",[29],{"name":26,"role":30,"phone":31,"phoneExt":18,"email":32},"CONTACT","+852 3917 6709","hkusph@hku.hk",[34,52],{"facility":35,"status":36,"city":37,"state":18,"zip":18,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Laboratory of Data Discovery for Health","RECRUITING","Hong Kong","HK",{"type":40,"coordinates":41},"Point",[42,43],114.17469,22.27832,{"lat":43,"lon":42},[46,49,50],{"name":47,"role":30,"phone":48,"phoneExt":18,"email":32},"Kathy Leung, PhD","+852 3917 6735",{"name":26,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":47,"role":51,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"facility":5,"status":36,"city":37,"state":18,"zip":18,"country":37,"countryCode":38,"cosmosGeoPoint":53,"geoPoint":55,"contacts":56},{"type":40,"coordinates":54},[42,43],{"lat":43,"lon":42},[57,58,59],{"name":47,"role":30,"phone":48,"phoneExt":18,"email":32},{"name":26,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":47,"role":51,"phone":18,"phoneExt":18,"email":18},{"type":27,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Joseph Tsz Kei Wu","Professor",[64,66],{"name":35,"class":65},"INDIV",{"name":67,"class":68},"Hospital Authority, Hong Kong","OTHER_GOV","100595831","developing-an-ai-pharmacy-chatbot-for-the-population-of-hong-kong-100595831",false,"NCT07037563","Developing an AI Pharmacy Chatbot for the Population of Hong Kong","Inclusion Criteria:\n\n* Patients aged 18 years or older diagnosed with either hyperglycaemia, hypertension, or hyperlipidaemia, and currently receiving medication prescribed by the Hospital Authority in Hong Kong.\n* Caregivers aged 18 years or older for patients described above.\n\nExclusion Criteria:\n\n* There is no exclusion criterion, but they should meet the inclusion criteria above.",true,"ALL","18 Years",{"count":79,"type":80},280,"ESTIMATED","INTERVENTIONAL",[83],"NA","The primary objective of this study is to is to develop a conversational AI service (chatbot) in Hong Kong to assist patients and caregivers with inquires related to Hospital Authority (HA)-prescribed medications, and to evaluate its effectiveness in answering medication-related questions. The main questions it aims to answer are:\n\n1. How satisfied are the patients and caregivers with this pharmacy chatbot?\n2. How will the pharmacy chatbot impact eligible patients or caregivers on their (or the patient they are caring for) medication adherence, knowledge, and the consultation time with HA pharmacists?\n\nThere will be an intervention group and a control group:\n\n1. The intervention group will be invited to use the AI Pharmacy Chatbot online for 7 days through WhatsApp, a commonly used social media platform in Hong Kong. They can inquire about their medications prescribed under HA and get instant, validated answers from the chatbot.\n2. The control group will not use the chatbot during the intervention period.\n\nTo evaluate the chatbot's usability, researchers will measure patient satisfaction through usability questionnaires issued to the intervention group after their intervention period. Differences in medication adherence, medication knowledge, and HA pharmacist consultation time will also be measured between the intervention and control groups after the intervention period, to determine the chatbot's impact.",[86,87,88,89],"Hyperglycaemia","Hypertension","Hyperlipidaemia","Artificial Intelligence (AI)",[91,92,93,94],"Chatbot","Intelligent Conversational Agent","Artificial Intelligence","Implementation Science","2025-06-17",{"date":97,"type":98},"2025-06-25","ACTUAL",{"date":100,"type":80},"2025-06",{"date":102,"type":80},"2026-10-31",{"name":5,"class":6},2]